Shchepotin I B, Soldatenkov V, Buras R R, Nauta R J, Shabahang M, Evans S R
Department of Surgery, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20007.
Anticancer Res. 1994 May-Jun;14(3A):1027-31.
Combined verapamil(V) and hyperthermia(HT) showed a significant decrease in HT29 and SW-620 cell counts by 61.5% and 77.6%, respectively, when compared to control. V in conjunction with 5-FU significantly reduced HT-29 count by 37% in comparison to 5-FU alone, and did not enhance the growth inhibitory effect of 5-FU on SW-620. HT did not enhance the growth inhibition seen with 5-FU treatment alone on HT-29, while this combination significantly decreased SW-620 cell count by 28.9% in comparison to administration of 5-FU alone. Joint administration of V and HT with 5-FU appeared to have a possible synergistic effect and reduced HT-29 count by 90% when compared to control. 5-FU alone or in different combinations with V and HT, as well as combination V+HT, results in apoptosis.